Approval · Notice of Compliance 32772 · 2024
BUPRIXA: Notice of Compliance 32772
Issued January 30, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32772
- Date
- January 30, 2024
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative - Manufacturer and Product Name Change
- Canadian reference product
- VETERGESIC MULTIDOSE (Ceva Animal Health Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUPRIXA | 02542536 | Approved |
Medicinal ingredients
- BUPRENORPHINE 0.3 MG per ML